Abstract The E‐cigarette or Vaping product‐Associated Lung Injury (EVALI) causes severe acute respiratory failure and, in some cases, death. Most…
Abstract In the summer of 2019, a cluster of cases were observed with users of battery-operated or superheating devices presenting…
Abstract The cannabinoid receptors CB1R and CB2R are members of the G protein-coupled receptor (GPCR) family. These receptors have recently…
Abstract As of February 18, 2020, the e-cigarette, or vaping, product use associated lung injury (EVALI) outbreak caused the hospitalization…
Abstract During the summer of 2019, cases of lung injury associated with vaping emerged in North America, including among individuals…
Abstract Electronic cigarette, or vaping, products (EVP) heat liquids (“e-liquids”) that contain substances (licit or illicit) and deliver aerosolized particles…
Abstract E-cigarette or vaping use-associated lung injury (EVALI) was identified with the incidents of a multi-state outbreak of acute lung…
Abstract E-cigarette or vaping product use-associated lung injury (EVALI) is a serious pulmonary condition that is associated with the extended…
Abstract Incidence of e-cigarette, or vaping, product use-associated lung injury (EVALI) has been linked to the vaping of tetrahydrocannabinol (THC)…
Abstract E-cigarette, or vaping, product (EVP) use has increased dramatically in the United States over the last 4 years, particularly…